Reversible relapse of pemphigus foliaceus triggered by topical imiquimod suggests that Toll-like receptor 7 inhibitors may be useful treatments for pemphigus.
Sebaratnam
D F
DF
Martin
L K
LK
Rubin
A I
AI
Tran
K
K
Pas
H H
HH
Marr
P J
PJ
Edmonds
J
J
Murrell
D F
DF
D000276:Adjuvants, Immunologic / Q000009:adverse effects*; D000287:Administration, Topical; D000634:Aminoquinolines / Q000009:adverse effects*; D002280:Basal Cell Carcinoma / Q000188:drug therapy / Q000473:pathology; D005260:Female; D006801:Humans; D000077271:Imiquimod; D008875:Middle Aged; D010392:Pemphigus / Q000139:chemically induced* / Q000188:drug therapy; D012878:Skin Neoplasms / Q000188:drug therapy / Q000473:pathology; D051199:Toll-Like Receptor 7 / Q000037:antagonists & inhibitors*; D016896:Treatment Outcome
D000276:Adjuvants, Immunologic; D000634:Aminoquinolines; D051199:Toll-Like Receptor 7; D000077271:Imiquimod